The anticomplement immunofluorescence (ACIF) test was compared with complement fixation and fluorescent antibody to membrane antigen procedures for the detection of antibody to varicella-zoster virus. All of 50 sera from pregnant women contained antibody measured by ACIF (titer, -1:10); only 27 (54%) were positive by complement fixation (P < 0.01). For 16 paired sera obtained before and after varicella-zoster virus infection and tested by ACIF and fluorescent antibody to membrane antigen, the results agreed in 27 determinations (sensitivity, 94%; specificity, 81% (ii) ACIF. Our ACIF procedure (10) was adapted from that of Reedman and Klein (8), who used the technique for measuring antibodies to the nuclear antigen of Epstein-Barr virus. Briefly, serial dilutions of heat-inactivated (56°C for 30 min) test sera were placed on slides containing VZV-infected cells. After 30 min of incubation at 35°C in a moist chamber, the slides were washed twice in phosphate-buffered saline containing Ca2" and Mg2" for 5 min each time. After rinsing three times with deionized water, the slides 373 on August 27, 2017 by guest
Immunocompromised patients who risk severe varicella-zoster virus (VZV) infections may be protected with specific immuno globulin (2). The most sensitive method for the determination of antibodies, and thus immunity, to VZV infection has been the fluorescent antibody to membrane antigen (FAMA) test, as compared with conventional indirect immunofluorescence and complement fixation (CF) procedures (12) . Re (ii) ACIF. Our ACIF procedure (10) was adapted from that of Reedman and Klein (8) , who used the technique for measuring antibodies to the nuclear antigen of Epstein-Barr virus. Briefly, serial dilutions of heat-inactivated (56°C for 30 min) test sera were placed on slides containing VZV-infected cells. After 30 min of incubation at 35°C in a moist chamber, the slides were washed twice in phosphate-buffered saline containing Ca2" and Mg2" for 5 min each time. After rinsing three times with deionized water, the slides were kept at 35'C for 5 min to dry. One drop ("0.025 ml) of a previously determined dilution of guinea pig complement (Cordis Laboratories, Miami, Fla.) was added to each well, followed by incubation of each slide at 35'C for 30 min. After two 5-min washes in phosphate-buffered saline and three rapid rinses with deionized water, the slides were dried again at incubator temperature (35'C). One drop (=0.025 ml) of a previously established dilution of fluorescein-conjugated anti-guinea pig complement (C3) (Cappel Laboratories, Downington, Pa.) was added to all wells. The slides were incubated, washed, and dried as described above. A no. 1 cover slip (24 by 50 mm; American Scientific Products, Inc., Minneapolis, Minn.) was placed on each slide over 50% glycerol-phosphatebuffered saline (vol/vol) mounting fluid. Phosphate 
RESULTS
The method for preparation of VZV-infected cells and their deposition on the slides facilitated the interpretation of specific fluorescence patterns. In the first step, VZV-infected cells were harvested after approximately 25% of the cells were infected. One drop of this cell suspension was placed in each well or mixed with uninfected cells, and the slide was incubated at 35°C in a moist chamber for about 24 h. The cells on the slide were then fixed with acetone. In this manner, the virus-infected cells formed plaque-like areas among normal cells and gave the appearance, after fluorescence staining, of VZV-specific cytopathic effects.
The ACIF procedure was vastly superior to the CF test for detecting antibody to VZV. All of 50 sera from pregnant women, submitted for rubella virus antibody testing, had detectable antibody by ACIF testing, whereas only 27 (specificity, 50%) had detectable immunity by CF testing (P < 0.01).
For 16 paired sera, obtained before and after VZV infection, results agreed in 15 (94%). Se- (Fig. 1) . For routine testing of immune status to VZV, ACIF test results compared very well with FAMA test results. Of 99 sera, 5 were positive for VZV antibody by FAMA but negative by ACIF (sensitivity, 92.5%); 5 were positive by ACIF and negative by FAMA (specificity, 88%).
Of the remaining 89 sera tested, 57 were positive and 32 were negative by both methods. The presence of antinuclear antibodies prevented the interpretation of ACIF results in three cases.
Of 10 patients with HSV infections, indicated by serological rises in antibody testing (ACIF procedure), 7 (70%) had apparent heterotypic antibody rises to VZV. Cross-reactions to HSV and CMV in patients with antibody rises to VZV or CMV were uncommon (1 out of 20) (Table 2 ).
DISCUSSION
Our results differ from those of Shigeta et al. (9) in several respects. In their study, ACIF titers were two-to fourfold lower than those obtained by FAMA, and in a survey of 59 healthy adults, only 4 (7%) had detectable antibody. Of 200 adult blood donors in our community, only 2 (1%) had no detectable antibodies to VZV by ACIF testing. Furthermore, over 85% of these donors had antibody tiers .1:40. Al 
